However, c-MYC (and other members of its family) is rarely mutated in cancers but is activated by gene amplification or translocation, and the resulting abundance of c-MYC activity leads to cellular immortality associated with blockade of differentiation [2, 3]. The gene discussed is MYC; the disease is cancer.